Focus on children, urges president of SA Society of Psychiatrists

Focus on children, urges president of SA Society of Psychiatrists

There are serious gaps in psychiatry regarding treatment, prevention and care for children and adolescents in South Africa. Offering solutions, Dr Anusha Lachman tells Spotlight psychiatric services should be offered in ways that are Afro-centric and culturally sensitive.

Read More

Some people still sidelined at health facilities – how do we fix it?

Some people still sidelined at health facilities – how do we fix it?

Nthusang Lefafa looks at the latest Ritshidze report for key populations and speaks to some public healthcare experts about possible solutions to challenges facing those marginalised groups who carry a high burden of the HIV pandemic.

Read More

Stigma, lack of awareness holding back use of HIV prevention pills, experts say

Stigma, lack of awareness holding back use of HIV prevention pills, experts say

Over the last four years South Africa has taken large strides in making HIV prevention pills available at public sector clinics, but uptake has not been as good as some may have hoped. Thabo Molelekwa asks several experts why this might be.

Read More

Obesity and HIV: Semaglutide should be rolled out in SA, says Dr Nomathemba Chandiwana

Obesity and HIV: Semaglutide should be rolled out in SA, says Dr Nomathemba Chandiwana

Obesity is a public health crisis in South Africa, similar to HIV in the late 1990s, Dr Nomathemba Chandiwana tells Spotlight on the sidelines of the Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado. She also presented research that found lifestyle behaviour changes had a limited effect on reversing weight gain in people living with HIV.

Read More

New TB drug shows promise, but experimental vaccine disappoints

New TB drug shows promise, but experimental vaccine disappoints

While three new tuberculosis (TB) medicines have been registered in South Africa over the last decade, TB treatment still comes with several side effects and requires taking multiple different medicines, typically for six or more months. The search for better TB medicines got a boost last week with the presentation of promising findings from a study conducted in South Africa on an experimental drug called quabodepistat. Elri Voigt reports on this and other TB studies presented at the Conference on Retroviruses and Opportunistic Infections (CROI) in Denver, Colorado.

Read More

Pilot project in SA now offering HIV prevention injection

Pilot project in SA now offering HIV prevention injection

A new HIV prevention injection is now available to a select number of people in South Africa. That a single shot provides two months of protection is one of the injection’s major selling points. In this story, Elri Voigt unpacks how much of the jab is available, who is choosing to get it and what other anti-HIV drugs are being rolled out.

Read More

There is a ‘worrying’ resurgence of sexually transmitted infections in Gauteng

There is a ‘worrying’ resurgence of sexually transmitted infections in Gauteng

There’s a resurgence of sexually transmitted infections (STIs) in South Africa and around the world. The Gauteng Department of Health recently reported an increase of newly acquired STIs, in particular gonorrhoea and chlamydia. This spike in cases call for management guidelines and awareness programmes to be reviewed, reports Ufrieda Ho.

Read More

EDITORIAL | With elections and NHI, this is a big year for healthcare in SA

EDITORIAL | With elections and NHI, this is a big year for healthcare in SA

South Africa is barrelling towards its most consequential and most competitive national and provincial elections since 1994. Spotlight editor Marcus Low asks what is on the line in these elections from a healthcare perspective and argues that the stakes are particularly high when it comes to NHI and the Gauteng and KwaZulu-Natal provincial health departments.

Read More

Yogan Pillay | This is how SA can meet its HIV targets

Yogan Pillay | This is how SA can meet its HIV targets

To respond to the call to end AIDS by 2030, Dr Yogan Pillay argues it is firstly critical to agree on what we mean by ending AIDS. Secondly, he suggests it is important to have accurate and granular data that can inform a more targeted approach to reaching those people that the health system typically does not reach.

Read More

Analysis: Where we are with NIMART 13 years later

Analysis: Where we are with NIMART 13 years later

Once South Africa had closed the door on state-sponsored AIDS denialism in 2008, a critical question was how to offer HIV treatment to as many eligible people as possible as quickly as possible. Given that the health system did not have enough doctors for the job, it was decided in 2010 to rope in nurses to help out. Tiyese Jeranji asks where things stand with Nurse Initiated and Managed Antiretroviral treatment (NIMART) 13 years later.

Read More

Interview: “I used that anger to feed my activist’s soul,” says former TAC General Secretary

Interview: “I used that anger to feed my activist’s soul,” says former TAC General Secretary

In 2001, at age 22, Vuyiseka Dubula-Majola joined the Treatment Action Campaign in its fight to bring antiretrovirals to South Africa. Today, she walks the streets of Geneva in Switzerland to get to her job as head of the Global Fund’s community, rights and gender department. Biénne Huisman spoke with Dubula-Majola about her remarkable journey, balancing activism with diplomacy, and the struggle “to build and regain the dignity of poor people around the globe”.

Read More